Slow-release DHEA for asthma in adults
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests a slow-release form of the hormone DHEA as an add-on treatment for asthma. It aims to see if it can improve asthma control and reduce inflammation, possibly helping you breathe better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- You have been diagnosed with asthma and your breathing tests show it's reversible (improves with medication).
- You have been using a daily controller inhaler (inhaled corticosteroid) for at least 2 months.
- You are a non-smoker (no cigarettes, vaping, or nicotine products).
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug (called JNJ-95597528) taken as a pill, to see if it can reduce asthma attacks and improve control in people with moderate to severe asthma that isn't well controlled by current inhalers. It may be a new option to help reduce airway inflammation and improve your breathing.
This study tests a new three-part asthma inhaler (CHF 5993) in people whose asthma isn't well-controlled even though they're already using two standard asthma medicines together. The goal is to see if adding this new medicine helps control asthma better.
This trial tests whether a new inhaler (CHF5993) works as well as the current standard for adults with mild to moderate asthma. It compares how well the medicine controls asthma and opens airways.
This study tests an investigational medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with current treatments. The goal is to see if it can reduce asthma attacks and improve breathing.
This study is testing an investigational medication for people with uncontrolled asthma. Participants must have moderate-to-severe asthma, be on appropriate maintenance therapy, and meet specific safety criteria.
This study tests a new inhaled medication (given through a device you breathe in) for adults with asthma. It is designed to reduce inflammation and improve breathing, and may help people who have not found relief with standard daily inhalers.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.